Article
Modelling Crebbp loss in BCL2 driven non-Hodgkin's lymphoma
2016-01-01
Abstract excerpt
Non-Hodgkin’s lymphomas (NHL) are a spectrum of hematopoietic cancer accounting for 4% of new cancer diagnoses each year. Approximately 95% of all NHL are of B-cell origin; diffuse large B-cell lymphomas (DLBCL) and follicular lymphoma (FL) accounting for 30-40% and 20% of B-NHL respectively. Recent human mutation profiling and resequencing studies have shown that CREBBP and BCL2 are frequently mutated, early even...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fec8825b-3300-574b-a6c8-c9799ede27b3
- DOI
- 10.25560/58194
